Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

Also called NCT02539160

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 101 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02539160
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02539160. Randomized; no masking; primary purpose treatment. Start 2016-02 (actual); primary completion 2019-11-14 (actual). Results posted on 2022-01-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease
Condition
Diabetes Mellitus
Intervention (Drug)
ticagrelor
Lead sponsor
University of Florida (class: other)

Record details

Record id
cardio:ct-nct02539160
Content hash
e7e7d2b001b4648f9721e575ce76a285202979fb3765952f3504dd267264c4b4